Research shows experimental anti-amyloid drug reduced cognitive symptom risk by 50% in people with rare genetic mutations ...
Amvuttra operates via RNA interference (RNAi), a groundbreaking technology that inhibits the production of the TTR protein in ...
The brain's immune cells removed plaques and helped restore a healthier environment in the brains of immunized patients. For over 30 years, scientists have focused on treating Alzheimer’s disease by ...
A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback